Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 DDI study of TAK-272 with itraconazole, digoxin, and midazolam in healthy adults
jRCT2080222758Phase 1
- Sponsor
- Takeda
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of imarikiren (2 cohorts), sponsored by Takeda. Primary endpoints: Effect of itraconazole on TAK-272 pharmacokinetics, Effect of TAK-272 on digoxin pharmacokinetics and 1 more.
02
Drugs
imarikiren
Beyond the preview
Go deeper on jRCT2080222758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222758.